Incannex Healthcare (IXHL) Change in Accured Expenses (2023 - 2026)

Incannex Healthcare (IXHL) posted quarterly Change in Accured Expenses of $458000.0 for Q1 2026, down 68.44% year-on-year from $1.5 million in Q1 2025, and up 940.91% on a QoQ basis from $44000.0 in Q4 2025.

Incannex Healthcare (IXHL) Change in Accured Expenses (2023 - 2026) Analysis & Trends

Incannex Healthcare (IXHL) has reported Change in Accured Expenses for 4 consecutive years, with $458000.0 the latest figure, recorded in Q1 2026.

  • Quarterly Change in Accured Expenses fell 68.44% year-over-year to $458000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$4.1 million (down 223.79% YoY) and the FY2025 annual result came in at $1.4 million, down 54.18% from the prior year.
  • Change in Accured Expenses grew to $458000.0 in Q1 2026 per IXHL's latest filing, from $44000.0 in the prior quarter.
  • Over the last five years, Change in Accured Expenses for IXHL reached as high as $3.3 million in Q3 2024 and fell as low as -$5.4 million in Q3 2025.
  • A 4-year average of -$44181.8 and a median of $458000.0 in 2026 frame the typical range for Change in Accured Expenses.
  • The largest YoY upside for Change in Accured Expenses was 955.04% in 2024 against a maximum downside of 567.79% in 2024.
  • Year by year, Change in Accured Expenses stood at $891000.0 in 2023, then tumbled by 567.79% to -$4.2 million in 2024, then jumped by 101.06% to $44000.0 in 2025, then jumped by 940.91% to $458000.0 in 2026.
  • According to Business Quant data, Change in Accured Expenses over the past three periods registered $458000.0, $44000.0, and -$5.4 million for Q1 2026, Q4 2025, and Q3 2025 respectively.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Change in Accured Expenses (Qtr)
1 Haleon 89.69 Bn 87.82 Bn - -
2 Teva Pharmaceutical Industries 35.84 Bn 32.10 Bn 1.97 Bn -144.00 Mn
3 Zoetis 32.67 Bn 30.73 Bn 1.62 Bn -234.00 Mn
4 Takeda Pharmaceutical 27.69 Bn 23.63 Bn 4.39 Bn -
5 United Therapeutics 23.12 Bn 20.97 Bn 648.10 Mn -12.70 Mn
6 RedHill Biopharma 21.80 Bn 21.80 Bn - -
7 Viatris 20.24 Bn 18.44 Bn 1.16 Bn -
8 Neurocrine Biosciences 17.83 Bn 16.51 Bn 800.70 Mn -14.30 Mn
9 Elanco Animal Health 12.64 Bn 12.22 Bn 785.00 Mn -
10 Incannex Healthcare 37.17 Mn 37.17 Mn - 458,000.00

Historic Data

Download Data
DateValue
Mar 31, 2026 458,000.00
Mar 31, 2026 458,000.00
Dec 31, 2025 44,000.00
Dec 31, 2025 44,000.00
Sep 30, 2025 -5.40 Mn
Sep 30, 2025 -5.40 Mn
Jun 30, 2025 793,000.00
Jun 30, 2025 793,000.00
Mar 31, 2025 1.45 Mn
Mar 31, 2025 1.45 Mn
Dec 31, 2024 -4.17 Mn
Dec 31, 2024 -4.17 Mn
Sep 30, 2024 3.31 Mn
Sep 30, 2024 3.31 Mn
Jun 30, 2024 2.72 Mn
Jun 30, 2024 2.72 Mn
Mar 31, 2024 -202,000.00
Mar 31, 2024 -202,000.00
Dec 31, 2023 891,000.00
Dec 31, 2023 891,000.00